Industry veteran will draw on unique mix of scientific and business acumen to support Company’s efforts to combat cancer with growing portfolio of novel myeloid-targeting therapies CAMBRIDGE, Mass., March. 31, 2021 /PRNewswire/ — Myeloid Therapeutics, Inc., a clinical-stage immunology company focused on combining RNA insights with cutting edge technologies for new cancer therapies, today announced […]